Retatrutide (20 mg) | GLP-1/GIP/Glucagon Triple Agonist | COA Verified | ≥99% Purity
Product Details
Retatrutide is an investigational triple-receptor agonist studied for its activity on GLP-1, GIP, and glucagon receptors—key pathways involved in metabolic regulation, appetite signaling, energy balance, and body composition dynamics.
The 20mg high-strength format supports advanced research protocols exploring glucose homeostasis, lipid metabolism, thermogenic signaling, and systemic metabolic adaptation, making it ideal for comprehensive metabolic and cardiometabolic pathway investigations.
Product Highlights
-
Triple-receptor metabolic research peptide (GLP-1, GIP, glucagon)
-
Ultra high-strength 20mg format for intensive research protocols
-
Studied for appetite, satiety, and hunger signaling pathways
-
Supports glucose metabolism and insulin response research
-
Investigated for energy expenditure and thermogenesis mechanisms
-
Research-grade peptide formulation
Specifications
| Brand | |
|---|---|
| MAL Number | |
| Series | |
| Model | |
| SKU | |
| Product Form | |
| Ingredients | |
| Pack Type | |
| Net Content | |
| Days of Supply | |
| Recommended User | |
| Usage Instructions | |
| Storage Instructions | |
| Warranty Type |
Potential Health & Wellness Benefits
Quality Assurance
Why Choose Elite Bio Compounds?
Product Includes: